FindTrial
Sign In

Combination of inflammatory biomarkers with cystatin C and urine N-acetyl-ß-D-glucosaminidase to predict acute kidney injury and adverse outcomes in critically ill patients: a prospective cohort study

Combination of inflammatory biomarkers with cystatin C and urine N-acetyl-ß-D-glucosaminidase to predict acute kidney injury and adverse outcomes in critically ill patients: a prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094771
Enrollment
Unknown
Registered
2024-12-27
Start date
2024-12-27
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute kidney injury

Interventions

Observation group:None

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years; 2.Written informed consent signed by the patient or his/her representative;

Exclusion criteria

Exclusion criteria: 1.Those receiving renal replacement therapy prior to ICU admission; 2.Patients with end-stage renal disease (CKD stage 5 patients); 3.Patients after nephrectomy; 4.Patients with a history of renal transplantation; 5.Pregnant women; 6.Those refusing to provide informed consent;

Design outcomes

Primary

MeasureTime frame
Urine N-acetyl-ß-D-glucosaminidase;Acute kidney injury;—

Countries

China

Contacts

Public ContactSheng Zhang

PEKING UNIVERSITY SHENZHEN HOSPITAL

zs80icu@163.com+86 755 83923333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026